Customize Consent Preferences

We use cookies to help you navigate efficiently and perform certain functions. You will find detailed information about all cookies under each consent category below.

The cookies that are categorized as "Necessary" are stored on your browser as they are essential for enabling the basic functionalities of the site. ... 

Always Active

Necessary cookies are required to enable the basic features of this site, such as providing secure log-in or adjusting your consent preferences. These cookies do not store any personally identifiable data.

No cookies to display.

Functional cookies help perform certain functionalities like sharing the content of the website on social media platforms, collecting feedback, and other third-party features.

No cookies to display.

Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics such as the number of visitors, bounce rate, traffic source, etc.

No cookies to display.

Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.

No cookies to display.

Advertisement cookies are used to provide visitors with customized advertisements based on the pages you visited previously and to analyze the effectiveness of the ad campaigns.

No cookies to display.

Partners

Strategic partnerships will allow us to reach our goals

Grants

ERC PoC

PoC Validation

DTS

Biomarker Validation

CRAASH Barcelona

Program that helps European research teams launch successful diagnostic innovations to improve health and patient care

FIPSE

Ayudas para financiar estudios de viabilidad de las innovaciones en Salud

AECC INNOVA

Lead Optimization

DTS

PoC in CRC

Torres Quevedo

Ayuda PTQ2021-012018 financiada por MCIN/AEI

AGAUR Doctorat Industrial

NEOTEC

SNEO-20231204

MISIONES PERTE

MIG-20231023 – IMPACT Photonics – Investigación para la Integración de Nuevas Arquitecturas Sensoras de Fotónica Integrada Multiplexada y Terahercios Hiperespectrales para un Sistema Microfluídico In Vitro para Monitorizar Tratamientos Farmacológicos contra el Cáncer

Our investors

AtG Therapeutics is a preclinical stage drug development biotech that specialises in the discovery of metabolic adaptation targets and therapies to treat advanced cancer

AtG is currently looking for investors in order to fund the preclinical development of AtG-153.

Would it be you?